Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Clinical trial NCT07109219 · RECRUITING

Trial details

NCT number: NCT07109219
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia (B-ALL)

Start date: 2025-11-12
Primary completion: 2028-04-28
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.